Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
Planegg/Martinsried, September 14, 2024. Medigene AG ( Medigene or the "Company", FSE: MDG1, Prime Standard ) , an oncology platform company focused on the research and development of T cell receptor ( TCR ) -guided therapies for the treatment of cancer, presented updates for its T cell receptor ...
| Ticker |
Sentiment |
Impact |
|
MDGED
|
Neutral
|
7 %
|
|
WXXWY
|
Neutral
|
2 %
|
|
BNTX
|
Neutral
|
2 %
|
